Veerhealth Care Fair Value
Veerhealth Care (VEERHEALTH) average fair value is ₹58.85 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹23.34 (+152.15%), fair value range ₹7.14–₹251.9. See VEERHEALTH P/B ratio history to compare market price against book value per share.
Fair Value Analysis Export
VEERHEALTH Fair Value vs Current Price — Valuation Summary
VEERHEALTH average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Also explore VEERHEALTH share price data to track price trends across different timeframes.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
VEERHEALTH Fair Value Analysis — Data Sources & Coverage
Veerhealth Care financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit Veerhealth Care stock price NSE.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
VEERHEALTH vs Healthcare Sector Peers — P/E, P/B & Market Cap
Veerhealth Care P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Sun Pharmaceutical | SUNPHARMA | 40.81 | 5.74 | ₹450,643 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Accretion Pharmaceuticals | ACCPL | 17.91 | 2.7 | ₹120 |
| Jeena Sikho Lifecare | JSLL | 40.38 | 23.07 | ₹7,944 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.